
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: Current progress and advances
Nishant Gandhi, Rakesh Kumar Tekade, Mahavir B. Chougule
Journal of Controlled Release (2014) Vol. 194, pp. 238-256
Open Access | Times Cited: 366
Nishant Gandhi, Rakesh Kumar Tekade, Mahavir B. Chougule
Journal of Controlled Release (2014) Vol. 194, pp. 238-256
Open Access | Times Cited: 366
Showing 1-25 of 366 citing articles:
Nanostructured lipid carriers: Promising drug delivery systems for future clinics
Ana Beloqui, Maria Ángelés Solinís, Alicia Rodríguez‐Gascón, et al.
Nanomedicine Nanotechnology Biology and Medicine (2015) Vol. 12, Iss. 1, pp. 143-161
Closed Access | Times Cited: 635
Ana Beloqui, Maria Ángelés Solinís, Alicia Rodríguez‐Gascón, et al.
Nanomedicine Nanotechnology Biology and Medicine (2015) Vol. 12, Iss. 1, pp. 143-161
Closed Access | Times Cited: 635
Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies
Wen Li, Han Zhang, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2016) Vol. 27, pp. 14-29
Closed Access | Times Cited: 585
Wen Li, Han Zhang, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2016) Vol. 27, pp. 14-29
Closed Access | Times Cited: 585
Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer
Gaofeng Liang, Yanliang Zhu, Doulathunnisa Jaffar Ali, et al.
Journal of Nanobiotechnology (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 524
Gaofeng Liang, Yanliang Zhu, Doulathunnisa Jaffar Ali, et al.
Journal of Nanobiotechnology (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 524
Composition design and medical application of liposomes
Mingyuan Li, Chunyang Du, Na Guo, et al.
European Journal of Medicinal Chemistry (2019) Vol. 164, pp. 640-653
Closed Access | Times Cited: 464
Mingyuan Li, Chunyang Du, Na Guo, et al.
European Journal of Medicinal Chemistry (2019) Vol. 164, pp. 640-653
Closed Access | Times Cited: 464
Recent progress in development of siRNA delivery vehicles for cancer therapy
Hyun Jin Kim, Ahram Kim, Kanjiro Miyata, et al.
Advanced Drug Delivery Reviews (2016) Vol. 104, pp. 61-77
Open Access | Times Cited: 388
Hyun Jin Kim, Ahram Kim, Kanjiro Miyata, et al.
Advanced Drug Delivery Reviews (2016) Vol. 104, pp. 61-77
Open Access | Times Cited: 388
siRNA Delivery Strategies: A Comprehensive Review of Recent Developments
Katyayani Tatiparti, Samaresh Sau, Sushil K. Kashaw, et al.
Nanomaterials (2017) Vol. 7, Iss. 4, pp. 77-77
Open Access | Times Cited: 375
Katyayani Tatiparti, Samaresh Sau, Sushil K. Kashaw, et al.
Nanomaterials (2017) Vol. 7, Iss. 4, pp. 77-77
Open Access | Times Cited: 375
Liposome-based drug co-delivery systems in cancer cells
Sepideh Zununi Vahed, Roya Salehi, Soodabeh Davaran, et al.
Materials Science and Engineering C (2016) Vol. 71, pp. 1327-1341
Closed Access | Times Cited: 278
Sepideh Zununi Vahed, Roya Salehi, Soodabeh Davaran, et al.
Materials Science and Engineering C (2016) Vol. 71, pp. 1327-1341
Closed Access | Times Cited: 278
miRNA nanotherapeutics for cancer
Aditya Ganju, Sheema Khan, Bilal Bin Hafeez, et al.
Drug Discovery Today (2016) Vol. 22, Iss. 2, pp. 424-432
Open Access | Times Cited: 272
Aditya Ganju, Sheema Khan, Bilal Bin Hafeez, et al.
Drug Discovery Today (2016) Vol. 22, Iss. 2, pp. 424-432
Open Access | Times Cited: 272
Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells
Gaofeng Liang, Shu Kan, Yanliang Zhu, et al.
International Journal of Nanomedicine (2018) Vol. Volume 13, pp. 585-599
Open Access | Times Cited: 251
Gaofeng Liang, Shu Kan, Yanliang Zhu, et al.
International Journal of Nanomedicine (2018) Vol. Volume 13, pp. 585-599
Open Access | Times Cited: 251
Co-delivery of chemotherapeutics and proteins for synergistic therapy
Chaoliang He, Zhaohui Tang, Huayu Tian, et al.
Advanced Drug Delivery Reviews (2015) Vol. 98, pp. 64-76
Closed Access | Times Cited: 202
Chaoliang He, Zhaohui Tang, Huayu Tian, et al.
Advanced Drug Delivery Reviews (2015) Vol. 98, pp. 64-76
Closed Access | Times Cited: 202
ABC Transporter-Mediated Multidrug-Resistant Cancer
Haneen Amawi, Hong‐May Sim, Amit K. Tiwari, et al.
Advances in experimental medicine and biology (2019), pp. 549-580
Closed Access | Times Cited: 195
Haneen Amawi, Hong‐May Sim, Amit K. Tiwari, et al.
Advances in experimental medicine and biology (2019), pp. 549-580
Closed Access | Times Cited: 195
Nanomaterials for Cancer Precision Medicine
Yilong Wang, Shuyang Sun, Zhiyuan Zhang, et al.
Advanced Materials (2018) Vol. 30, Iss. 17
Closed Access | Times Cited: 177
Yilong Wang, Shuyang Sun, Zhiyuan Zhang, et al.
Advanced Materials (2018) Vol. 30, Iss. 17
Closed Access | Times Cited: 177
Localized injection of miRNA-21-enriched extracellular vesicles effectively restores cardiac function after myocardial infarction
Yu Song, Cheng Zhang, Jinxiang Zhang, et al.
Theranostics (2019) Vol. 9, Iss. 8, pp. 2346-2360
Open Access | Times Cited: 175
Yu Song, Cheng Zhang, Jinxiang Zhang, et al.
Theranostics (2019) Vol. 9, Iss. 8, pp. 2346-2360
Open Access | Times Cited: 175
Mesenchymal stem cells as a double-edged sword in tumor growth: focusing on MSC-derived cytokines
Wenqing Liang, Xiaozhen Chen, Songou Zhang, et al.
Cellular & Molecular Biology Letters (2021) Vol. 26, Iss. 1
Open Access | Times Cited: 135
Wenqing Liang, Xiaozhen Chen, Songou Zhang, et al.
Cellular & Molecular Biology Letters (2021) Vol. 26, Iss. 1
Open Access | Times Cited: 135
Mononuclear phagocyte system blockade using extracellular vesicles modified with CD47 on membrane surface for myocardial infarction reperfusion injury treatment
Zilun Wei, Zhaoyang Chen, Yongchao Zhao, et al.
Biomaterials (2021) Vol. 275, pp. 121000-121000
Closed Access | Times Cited: 107
Zilun Wei, Zhaoyang Chen, Yongchao Zhao, et al.
Biomaterials (2021) Vol. 275, pp. 121000-121000
Closed Access | Times Cited: 107
Biopolymers based aerogels: A review on revolutionary solutions for smart therapeutics delivery
H. P. S. Abdul Khalil, Esam Bashir Yahya, Fauziah Jummaat, et al.
Progress in Materials Science (2022) Vol. 131, pp. 101014-101014
Open Access | Times Cited: 91
H. P. S. Abdul Khalil, Esam Bashir Yahya, Fauziah Jummaat, et al.
Progress in Materials Science (2022) Vol. 131, pp. 101014-101014
Open Access | Times Cited: 91
Targeting miRNAs and Other Non-Coding RNAs as a Therapeutic Approach: An Update
Emine Bayraktar, Recep Bayraktar, Hülya Öztatlıcı, et al.
Non-Coding RNA (2023) Vol. 9, Iss. 2, pp. 27-27
Open Access | Times Cited: 55
Emine Bayraktar, Recep Bayraktar, Hülya Öztatlıcı, et al.
Non-Coding RNA (2023) Vol. 9, Iss. 2, pp. 27-27
Open Access | Times Cited: 55
Drug resistance in ovarian cancer: from mechanism to clinical trial
Ling Wang, Xin Wang, Xueping Zhu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 46
Ling Wang, Xin Wang, Xueping Zhu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 46
Emerging role of exosomes in cancer therapy: progress and challenges
Jiale Li, Jiachong Wang, Zigui Chen
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 10
Jiale Li, Jiachong Wang, Zigui Chen
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 10
Nanocarrier-mediated co-delivery of chemotherapeutic drugs and gene agents for cancer treatment
Lin Kang, Zhonggao Gao, Wei Huang, et al.
Acta Pharmaceutica Sinica B (2015) Vol. 5, Iss. 3, pp. 169-175
Open Access | Times Cited: 178
Lin Kang, Zhonggao Gao, Wei Huang, et al.
Acta Pharmaceutica Sinica B (2015) Vol. 5, Iss. 3, pp. 169-175
Open Access | Times Cited: 178
Nanoformulations for combination or cascade anticancer therapy
Lei Miao, Shutao Guo, Chunxiang Lin, et al.
Advanced Drug Delivery Reviews (2017) Vol. 115, pp. 3-22
Open Access | Times Cited: 164
Lei Miao, Shutao Guo, Chunxiang Lin, et al.
Advanced Drug Delivery Reviews (2017) Vol. 115, pp. 3-22
Open Access | Times Cited: 164
CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice
Farhad Jadidi‐Niaragh, Fatemeh Atyabi, Ali Rastegari, et al.
Journal of Controlled Release (2016) Vol. 246, pp. 46-59
Closed Access | Times Cited: 161
Farhad Jadidi‐Niaragh, Fatemeh Atyabi, Ali Rastegari, et al.
Journal of Controlled Release (2016) Vol. 246, pp. 46-59
Closed Access | Times Cited: 161
Augmented delivery of gemcitabine in lung cancer cells exploring mannose anchored solid lipid nanoparticles
Namrata Soni, Neetu Soni, Ashok Pandey, et al.
Journal of Colloid and Interface Science (2016) Vol. 481, pp. 107-116
Closed Access | Times Cited: 150
Namrata Soni, Neetu Soni, Ashok Pandey, et al.
Journal of Colloid and Interface Science (2016) Vol. 481, pp. 107-116
Closed Access | Times Cited: 150
Synergistic Cisplatin/Doxorubicin Combination Chemotherapy for Multidrug-Resistant Cancer via Polymeric Nanogels Targeting Delivery
Hai-Qiu Wu, Haojie Jin, Cun Wang, et al.
ACS Applied Materials & Interfaces (2017) Vol. 9, Iss. 11, pp. 9426-9436
Closed Access | Times Cited: 150
Hai-Qiu Wu, Haojie Jin, Cun Wang, et al.
ACS Applied Materials & Interfaces (2017) Vol. 9, Iss. 11, pp. 9426-9436
Closed Access | Times Cited: 150
The Warburg effect and glucose-derived cancer theranostics
Rakesh Kumar Tekade, Xiankai Sun
Drug Discovery Today (2017) Vol. 22, Iss. 11, pp. 1637-1653
Closed Access | Times Cited: 136
Rakesh Kumar Tekade, Xiankai Sun
Drug Discovery Today (2017) Vol. 22, Iss. 11, pp. 1637-1653
Closed Access | Times Cited: 136